Crossmark

How to respond when biomedical science and global health is under existential threat

Published Online: 2025-04-09

Published Print: 2025-05

Authors

Altmann, Daniel M.

Rasmussen, Angela L. https://orcid.org/0000-0001-9462-3169
License Information

Text and Data Mining valid from 2025-04-09

Version of Record valid from 2025-04-09
More Information

Article History

First Online: 9 April 2025

Competing interests

: D.M.A. has received honoraria for consultancies with AstraZeneca, Novavax, PfizerBioNtech and Oxford Immuotec. A.L.R. declares no competing interests.

Document is current